Circulating Cell-Free DNA from Colorectal Cancer Patients May Reveal High KRAS or BRAF Mutation Load. - Wikidata - wikimedia - TriplyDB

Circulating Cell-Free DNA from Colorectal Cancer Patients May Reveal High KRAS or BRAF Mutation Load.

Circulating Cell-Free DNA from Colorectal Cancer Patients May Reveal High KRAS or BRAF Mutation Load.

http://www.wikidata.org/entity/Q36865058

about

Cell-free nucleic acids as noninvasive biomarkers for colorectal cancer detection DNA studies using atomic force microscopy: capabilities for measurement of short DNA fragments EGFR-TKI resistance in NSCLC patients: mechanisms and strategies Origins, structures, and functions of circulating DNA in oncology Monitoring the dynamics of clonal tumour evolution in vivo using secreted luciferases Lengthening and shortening of plasma DNA in hepatocellular carcinoma patients.Digital detection of multiple minority mutants and expression levels of multiple colorectal cancer-related genes using digital-PCR coupled with bead-array EPMA position paper in cancer: current overview and future perspectives.Comparison of genetic and epigenetic alterations of primary tumors and matched plasma samples in patients with colorectal cancer Circulating Cell-Free Tumour DNA in the Management of Cancer.SNPase-ARMS qPCR: Ultrasensitive Mutation-Based Detection of Cell-Free Tumor DNA in Melanoma Patients.Single-Tubed Wild-Type Blocking Quantitative PCR Detection Assay for the Sensitive Detection of Codon 12 and 13 KRAS Mutations.The clinical utilization of circulating cell free DNA (CCFDNA) in blood of cancer patients.Determinants of recurrence after intended curative resection for colorectal cancer.Neutrophil extracellular traps: a walk on the wild side of exercise immunology.Role of Circulating Cell-Free DNA in Cancers.The role of cell-free DNA in predicting colorectal cancer prognosis.Blood circulating tumor DNA for non-invasive genotyping of colon cancer patients.Kinetic analysis, size profiling, and bioenergetic association of DNA released by selected cell lines in vitro.Clinical Applications of Liquid Biopsies in Gastrointestinal Oncology.KRAS mutation screening by chip-based DNA hybridization--a further step towards personalized oncology.Role of circulating free DNA in colorectal cancer.Liquid biopsies come of age: towards implementation of circulating tumour DNA.Integrating liquid biopsies into the management of cancer.Somatic mutation detection using various targeted detection assays in paired samples of circulating tumor DNA, primary tumor and metastases from patients undergoing resection of colorectal liver metastases Using circulating cell-free DNA to monitor personalized cancer therapy.Multi-marker analysis of circulating cell-free DNA toward personalized medicine for colorectal cancer The detection and significance of EGFR and BRAF in cell-free DNA of peripheral blood in NSCLC.Review of the clinical applications and technological advances of circulating tumor DNA in cancer monitoring.Fecal Recovery of Ingested Cellular DNA: Implications for Noninvasive Detection of Upper Gastrointestinal Neoplasms.Liquid biopsy in colon cancer: comparison of different circulating DNA extraction systems following absolute quantification of KRAS mutations using Intplex allele-specific PCR.Molecular Landscape and Treatment Options for Patients with Metastatic Colorectal Cancer.Incorporating Blood-based Liquid Biopsy Information into Cancer Staging: Time for a TNMB System?Clinical utility of circulating DNA analysis for rapid detection of actionable mutations to select metastatic colorectal patients for anti-EGFR treatment.A field guide for cancer diagnostics using cell-free DNA: From principles to practice and clinical applications.Clinical significance of disease-specific MYD88 mutations in circulating DNA in primary central nervous system lymphoma.Advances in liquid biopsy on-chip for cancer management: Technologies, biomarkers, and clinical analysis.Inhibition of DDR1-BCR signalling by nilotinib as a new therapeutic strategy for metastatic colorectal cancer.Computational optimisation of targeted DNA sequencing for cancer detection.Assessing the Impact of Circulating Tumor DNA (ctDNA) in Patients With Colorectal Cancer: Separating Fact From Fiction

P2860

Q26991998-DA68D943-64C0-43A2-847C-376647FCF944 Q28080979-2DD21180-3C63-4B8C-AFB2-FAF6859DAEF5 Q28394310-F93B2ECB-F2C4-45AE-BF51-E53A7FAFFE5F Q30249103-7FFC26B7-6F70-409F-BF29-60A1FD35665D Q33764406-90792B12-4DCA-4409-B3CE-62CB99BACAC8 Q35212779-CAB7E32C-829A-47F3-B57A-85B7842853D7 Q35447750-32DD53A2-46ED-40E5-961A-7ADEA6924718 Q35532215-FF39A170-30A9-4577-9AC1-46B524E9A48D Q35576801-DDBA2F78-B282-4598-B985-30B3D1417F19 Q35814162-CB3FDFD6-7E23-433A-9CC9-14C94EA048FD Q35839745-876497AB-EE21-4362-9FFA-13A47CE49DA7 Q35877954-669CBDF3-F705-4D69-9170-595F39B1CFD4 Q37225239-0B567463-7C47-4DFA-B514-085E8B21EA8B Q38265049-1FD96F2A-35D3-497E-84B6-99A914AFFCBF Q38287683-8C819A0B-0C84-4E75-A68D-24B492227C40 Q38591963-DB1EF582-7114-4F9D-83AC-5D3E9E99C54A Q38637642-08847FB1-7C4E-488F-8A5B-42E18054CC33 Q38699032-CAA716B7-190C-433E-B028-FEA648FD32B7 Q38711643-6BC19E67-B30A-4DA1-8884-289C998B7955 Q38800475-B373B4F5-761A-417D-A3EB-399D6DD76065 Q38906896-CB207F3B-AA45-45C5-8318-4503D8A26CCA Q39051652-57609645-E573-4371-8F85-02F6CEA1F998 Q39149201-8C220D98-5282-4C2B-8A55-62B4914B70FE Q39157824-EBE0A539-1E16-43D5-BF8F-D8FDB4A693C7 Q40431521-EACFF7AE-3041-4309-AC80-1FD070F98BCF Q40460053-FCEA178D-171B-4E82-8C26-525CB1A68108 Q41134871-C11118A5-9B3B-4ED1-A65E-D83603AFB834 Q41472736-4D9C6C3F-53F5-4A57-A6EC-D925DD3FCAD6 Q42687570-A327AF3F-222B-4564-9A04-C2D57872A6DC Q43337595-8DF63A72-2C1B-4EDD-BF2E-A789A71E1A0D Q43646628-4EAA04B5-8319-4AA6-BB7D-C5ACECCFEFAD Q45989066-50259BB5-C79E-478F-BD8E-7C6C180776AB Q47563363-2A43A936-5E73-453C-B9E5-DAEA0F1CD412 Q47984460-88ABF8E3-2E7B-44E0-AE69-E544BCC3F97E Q48178985-4F03321D-764E-4DB9-8E4E-3491160D71E3 Q48277300-CF41E402-6E7F-41B1-9F8C-95AE95B73358 Q49502117-92858204-84A0-4348-B412-C68622136F94 Q50036937-3916D990-CCCF-40AC-99DD-9BAA74E9964A Q53080459-E6744947-2BE0-44EF-ABAC-7200ABBFCB20 Q57170570-1DA30332-F26B-472C-B235-56F1192E9F41

P2860

Circulating Cell-Free DNA from Colorectal Cancer Patients May Reveal High KRAS or BRAF Mutation Load.

http://www.wikidata.org/entity/Q36865058

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

2013年论文

@zh

2013年论文

@zh-cn

name

Circulating Cell-Free DNA from ...... gh KRAS or BRAF Mutation Load.

@en

type

label

Circulating Cell-Free DNA from ...... gh KRAS or BRAF Mutation Load.

@en

prefLabel

Circulating Cell-Free DNA from ...... gh KRAS or BRAF Mutation Load.

@en

P1433

Q36865058-DD8B3940-7D48-4171-BAB7-8DC51EFA641D

P1476

Q36865058-C00EC05D-0A46-4BB7-9B73-734D3B19DDC2

P2093

Q36865058-07795E17-C929-4DEF-AA68-4162EBB6FD3B

Q36865058-62063815-7837-4637-BA3B-A7A9B5DDCD62

Q36865058-A683ACC3-43A8-494C-8136-7015720CE775

Q36865058-B70478B2-37CD-4D02-AA06-FFE840EE33FE

Q36865058-BBD56438-BDB9-411A-A2AE-EA2EE1CD07A8

Q36865058-CC24CCE4-6272-4385-A88C-2CC1C2121620

Q36865058-E8F450AC-1895-43C7-8265-E481DEDC0D0D

Q36865058-F29071AF-C90A-4382-A4E0-A0EA8044D501

Q36865058-FCEF2FA7-CC67-43CE-B38B-E08DF9E60BFE

P2860

Q36865058-02F04457-0419-4193-AD54-268CAA48D61C

Q36865058-0A2A39EE-73B5-40CD-8FF5-554272A4797A

Q36865058-1B8D474F-F030-4561-8CBF-F0BACC918052

Q36865058-2C22BA46-A6A7-4B76-B498-960203B993BF

Q36865058-2E646C6B-7DF4-45CC-9FB7-F9F00A6A656B

Q36865058-3030904C-D985-4D54-AD83-26772A7F35D8

Q36865058-31040218-849A-479B-81D8-705CAFC0477F

Q36865058-3648E599-EA9D-4B06-B39C-5A7641F5F0FF

Q36865058-385C8625-0CD8-4986-9926-0E682593989B

Q36865058-5D6F14B5-64E0-480E-BC74-B3B36ABDD220

P304

Q36865058-77EA0BB1-5DEE-4B5B-A51E-DF692A4982CB

P31

Q36865058-C6E1DD2D-A0AE-4017-8E22-91A2C253EB64

P356

Q36865058-25CF2641-CF88-4FA8-8ED2-F3745BFFD6BC

P433

Q36865058-7278817E-8348-432E-8063-3330555FF079

P478

Q36865058-C61B876F-724B-46E8-AE7E-A5D1F7884D18

P50

Q36865058-20535002-F228-4F0C-B1E8-3292B229A7B5

Q36865058-469A5893-590A-4818-81FF-4D5BCC2AD827

Q36865058-4A7957E0-24C9-46CA-B79C-67E6AB0747F8

Q36865058-B10C395A-07F6-4EF7-B6E0-0E366125DFF4

P577

Q36865058-A5204532-E0A9-4C13-88CE-13318F3903D8

P5875

Q36865058-812C23B7-5BBE-40D4-AE97-EFDF0EBFFA1F

P698

Q36865058-3ECC9803-67EE-478A-A88F-FF9E426DEED6

P921

Q36865058-D458823D-CB46-404E-9A60-3FAFF821B65C

P932

Q36865058-85FDF649-1010-4A81-826B-E29B64020B81

P356

P1433

Translational Oncology

P1476

Circulating Cell-Free DNA from ...... igh KRAS or BRAF Mutation Load

@en

P2093

Alain R Thierry

http://www.w3.org/2001/XMLSchema#string

Anne-Sophie Guedj

http://www.w3.org/2001/XMLSchema#string

Bruno Robert

http://www.w3.org/2001/XMLSchema#string

Celine Gongora

http://www.w3.org/2001/XMLSchema#string

Denis Pezet

http://www.w3.org/2001/XMLSchema#string

Evelyne Lopez-Crapez

http://www.w3.org/2001/XMLSchema#string

Franck Molina

http://www.w3.org/2001/XMLSchema#string

Maguy Del Rio

http://www.w3.org/2001/XMLSchema#string

Safia El Messaoudi

http://www.w3.org/2001/XMLSchema#string

P2860

KRAS mutations as an independent prognostic factor in patients with advanced colorectal cancer treated with cetuximab.

BRAF gene amplification can promote acquired resistance to MEK inhibitors in cancer cells harboring the BRAF V600E mutation.

The MIQE guidelines: minimum information for publication of quantitative real-time PCR experiments

BRAF mutation is frequently present in sporadic colorectal cancer with methylated hMLH1, but not in hereditary nonpolyposis colorectal cancer

Development of personalized tumor biomarkers using massively parallel sequencing

Circulating mutant DNA to assess tumor dynamics

Mutation detection by real-time PCR: a simple, robust and highly selective method.

Oncogene mutations, copy number gains and mutant allele specific imbalance (MASI) frequently occur together in tumor cells.

Analysis of mutations in DNA isolated from plasma and stool of colorectal cancer patients.

BRAF p.Val600Glu (V600E) Testing for Assessment of Treatment Options in Metastatic Colorectal Cancer.

P304

319-328

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1593/TLO.12445

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

6

http://www.w3.org/2001/XMLSchema#string

P50

Pierre-Jean Lamy

Florent Mouliere

Muriel Mathonnet

P577

2013-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

237014706

http://www.w3.org/2001/XMLSchema#string

P698

23730412

http://www.w3.org/2001/XMLSchema#string

P921

colorectal cancer

P932

3660801

http://www.w3.org/2001/XMLSchema#string